US FDA approval based on NEURO-TTRansform Phase III results showing Wainua demonstrated consistent and sustained benefit improving neuropathy impairment and quality of life. Additional regulatory reviews underway in rest of world.
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
